Christos Reppas

发表

FIP/AAPS Joint Workshop Report: Dissolution/In Vitro Release Testing of Novel/Special Dosage Forms

Todd L. Cecil, Cynthia K. Brown, Horst Dieter Friedel, 2011, AAPS PharmSciTech.

Workshop report: USP workshop on advancements in in vitro performance testing of drug products

Fernando J. Muzzio, Matthias G. Wacker, Changquan Calvin Sun, 2020 .

Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.

Filippos Kesisoglou, Christos Reppas, Jennifer B Dressman, 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

In vitro methods to assess drug precipitation in the fasted small intestine – a PEARRL review

Martin Kuentz, Christos Reppas, Jennifer B Dressman, 2018, The Journal of pharmacy and pharmacology.

In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects.

Talia Flanagan, Clive G. Wilson, Mai Anh Nguyen, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Characterization of the Contents of Ascending Colon to Which Drugs are Exposed After Oral Administration to Healthy Adults

Christos Reppas, Bertil Abrahamsson, Jennifer Dressman, 2009, Pharmaceutical Research.

Biorelevant Dissolution Testing to Predict the Plasma Profile of Lipophilic Drugs After Oral Administration

Christos Reppas, J. Dressman, C. Reppas, 2001, Pharmaceutical Research.

Insights into intermediate phases of human intestinal fluids visualized by atomic force microscopy and cryo-transmission electron microscopy ex vivo.

Anette Müllertz, Christos Reppas, Dimitrios G Fatouros, 2012, Molecular pharmaceutics.

Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.

Filippos Kesisoglou, Christos Reppas, Jennifer B Dressman, 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Characterization of Contents of Distal Ileum and Cecum to Which Drugs/Drug Products are Exposed During Bioavailability/Bioequivalence Studies in Healthy Adults

Eleni Karatza, Christos Reppas, C. Reppas, 2015, Pharmaceutical Research.

In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration

Anette Müllertz, Filippos Kesisoglou, Christos Reppas, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Biorelevant Dissolution Tests with the Flow-Through Apparatus?

Christos Reppas, John Hempenstall, C. Reppas, 2000 .

Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles.

Christos Reppas, Christian Wagner, Jennifer B Dressman, 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: Choosing the appropriate test media.

Christos Reppas, Jennifer Dressman, J. Dressman, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model.

Filippos Kesisoglou, Christos Reppas, Christian Wagner, 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms

Christos Reppas, Vinod P. Shah, Gordon L. Amidon, 2004, Pharmaceutical Research.

Degradation kinetics of metronidazole and olsalazine by bacteria in ascending colon and in feces of healthy adults.

Christos Reppas, Bertil Abrahamsson, B. Abrahamsson, 2011, International journal of pharmaceutics.

Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects

Christos Reppas, Erika S. Stippler, Christian Leuner, 2004, The Journal of pharmacy and pharmacology.

Mechanistic investigation of the negative food effect of modified release zolpidem

Xavier Pepin, Christos Reppas, Jennifer B Dressman, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Forecasting the In Vivo Performance of Four Low Solubility Drugs from Their In Vitro Dissolution Data

Christos Reppas, J. Dressman, C. Reppas, 1999, Pharmaceutical Research.